Rucaparib (AG014699) acetate is a highly effective oral inhibitor of PARP proteins, specifically targeting PARP-1, PARP-2, and PARP-3, with a Ki value of 1.4 nM for PARP1. Additionally, it exhibits inhibitory action on hexose-6-phosphate dehydrogenase (H6PD) to a moderate extent. Rucaparib acetate shows promise in the field of research for castration-resistant prostate cancer (CRPC). [1] [2] [3] [4]
Molecular Weight:
383.423
CAS Number:
[773059-23-7]
Formula:
C21H22FN3O3
Target:
Others|||PARP
T61657
* VAT and and shipping costs not included. Errors and price changes excepted
